The influence of diabetic retinopathy on quality of life: Interviews to guide the design of a condition-specific, individualised questionnaire: The RetDQoL

Patient Education and Counseling

Volumn 53, Issue 3, 2004, Pages 365-383

  Woodcock, Alison ^a   Bradley, Clare ^a   Plowright, Rosalind ^a   Ffytche, Timothy ^b   Kennedy Martin, Tessa ^c   Hirsch, Axel ^d  

^a UNIVERSITY OF LONDON   (United Kingdom)

^b HOSPITAL FOR TROPICAL DISEASES   (United Kingdom)

^c ELI LILLY AND COMPANY   (United States)

^d Krankenhaus Bethanien   (Germany)

Author keywords

Diabetes; Diabetic retinopathy; Quality of life; Visual impairment

Indexed keywords

ADULT; ANXIETY; CLINICAL ARTICLE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DISEASE SEVERITY; DOCTOR PATIENT RELATION; FEMALE; GERMANY; HOSPITAL; HUMAN; INTERPERSONAL COMMUNICATION; INTERVIEW; LASER COAGULATION; MALE; METHODOLOGY; MOVEMENT (PHYSIOLOGY); PRIORITY JOURNAL; QUALITATIVE ANALYSIS; QUALITY OF LIFE; QUANTITATIVE ANALYSIS; QUESTIONNAIRE; REVIEW; UNITED KINGDOM; VALIDATION PROCESS; VISUAL IMPAIRMENT; VITRECTOMY;

EID: 2942529178     PISSN: 07383991     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pec.2003.10.007     Document Type: Article

References (78)

1. Amos A., McCarty D., Zimmer P. The rising global burden of diabetes and its complications - estimates and projections to 2010. Diab. Med. 14:1997;S16
2. Evans J., Rooney C., Ashwood F., Dattani N., Wormwald R. Blindness and partial sight in England and Wales: April 1990-March 1991. Health Trends. 28:1996;5-12
3. Hamilton AMP, Ulbig M, Polkinghorne P. Management of diabetic retinopathy. London: BMJ Books; 1999.
4. Diabetic Retinopathy Research Group. Preliminary report on effects of photocoagulation therapy, Am J Ophthalmol 1976;81:383-96.
5. Early Treatment Diabetic Retinopathy Study Research Group. Early photocoagulation for diabetic retinopathy. ETDRS Report Number 9. Ophthalmology 1991;98:766-85.
6. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol 1985;103:1796-806.
7. McDonald H.R., Schatz H. Visual loss following panretinal photocoagulation for proliferative diabetic retinopathy. Ophthalmology. 92:1985;388-393
8. Seiberth V., Alexandridis E., Fengg W. Function of the diabetic retina after panretinal argon laser coagulation. Graefe's Arch. Clin. Exp. Ophthalmol. 225:1987;385-390
9. Han D.P., Mieler W.F., Burton T.C. Submacular fibrosis after photocoagulation for diabetic macular edema. Am. J. Ophthalmol. 113:1992;513-521
10. Lewis H., Schachat A.P., Haimann M.H., Haller J.A., Quinlan P., von Fricken M.A., Line S.L., Murphy R.P. Choroidal neovascularization after laser photocoagulation for diabetic macular edema. Ophthalmology. 97:1990;503-511
11. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy: clinical application of diabetic retinopathy study (DRS) findings, DRS Report Number 8. Ophthalmology 1981;88:583-600.
12. Menchini U., Scialdone A., Pietroni C., Carones F., Brancato R. Argon versus krypton Panretinal photocoagulation side effects on the anterior segment. Ophthalmologica. 201:1990;66-70
13. Mäntyjärvi M. Colour vision and dark adaptation in diabetic patients after photocoagulation. Acta Ophthalmol. 67:1989;113-118
14. Mäntyjärvi M. Colour vision in diabetic patients after photocoagulation a five-year follow-up. Acta Ophthalmol. 71:1993;514-518
15. Bailey C.C., Sparrow J.M. Visual symptomatology in patients with sight-threatening diabetic retinopathy. Diab. Med. 8:2001;883-888
16. Buckley S.A., Jenkins L., Benjamin L. Fields, DVLC and panretinal photocoagulation. Eye. 6:1992;623-625
17. Henricsson M., Heiji A. The effect of panretinal laser photoagulation on visual acuity. Acta Ophthalmol. 72:1994;570-575
18. Sims L.M., Stoessel K., Thompson J.T., Hirsch J. Assessment of visual-field changes before and after focal photocoagulation for clinically significant macular edema. Ophthalmologica. 200:1990;133-141
19. Khosla P.K., Rao V., Tewari H.K., Kumar A. Contrast sensitivity in diabetic retinopathy after panretinal photocoagulation. Ophthalm. Surg. 25:1994;516-520
20. Russell P.W., Sekuler R., Fetkenhour C. Visual function after panretinal photocoagulation a survey. Diab. Care. 8:1985;57-63
21. Mangione C.M., Berry S., Spritzer K., Janz N.K., Klein R., Owsley C., Lee P.P. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch. Ophthalmol. 16:1998;227-233
22. Ware JE, Brook RH, Williams KN, Stewart AL, Davies-Avery A. Conceptualisation and measurement of health for adults in the health insurance study, vol.1. Model of health and methodology. (Publication No. R-1987/1-HEW.) Santa Monica, CA: Rand Corporation; 1980.
23. EuroQol Group. EuroQol: a new facility for the measurement of health-related quality of life. Health Policy 1990;16:199-208.
24. Bergner M., Bobbitt R.A., Carter W.B., Gilson B.S. The Sickness Impact Profile: development and final revision of a health status measure. Med. Care. 19:1981;787-805
25. Bradley C. Importance of differentiating health status from quality of life. Lancet. 357:2001;7-8
26. Lee P.P., Spritzer K., Hays R.D. The impact of blurred vision on functioning and well-being. Ophthalmology. 104:1997;390-396
27. Wilson M.R., Coleman A.L., Yu F., Bing E.G., Sasaki I.F., Berlin K., Winters J., Lai A. Functional status and well-being in patients with glaucoma as measured by the Medical Outcomes Study Short Form-36 Questionnaire. Ophthalmology. 105:1998;2112-2116
28. Steinberg E.P., Tielsch J.M., Schein O.D., Javitt J.C., Sharkey P., Cassard S.D., et al. The VF-14: an index of functional impairment in patients with cataracts. Arch. Ophthalmol. 112:1994;630-638
29. Mangione C.M., Lee P.P., Pitts J., Gutierrez P., Berry S., Hays R.D. Psychometric properties of the National Eye Institute Visual Function Questionnaire (NEI-VFQ). Arch. Ophthalmol. 116:1998;1496-1504
30. Mangione C.M., Phillips R.S., Seddon J.M., Lawrence M.G., Cook E.F., Dailey R., Goldman L. Development of the 'Activities of Daily Living Scale': a measure of visual functional status. Med. Care. 30:1992;1111-1126
31. Bergner M., Bobbitt R.A., Carter W.B., Gilson B.S. The Sickness Impact Profile: development and final revision of a health status measure. Med. Care. 19:1981;787-805
32. Scott I.U., Schein O.D., West S., Bandeen-Roche K., Enger C., Folstein M.F. Functional status and quality of life measurement among ophthalmic patients. Arch. Ophthalmol. 112:1994;329-335
33. Desai P., Reidy A., Minassian D.C., Vafidis G., Bolger J. Gains from cataract surgery: visual function and quality of life. Br. J. Ophthalmol. 80:1996;868-873
34. Cruikshanks K.J., Fryback D.G., Nondahl D.M., Robinson N., Keesey U., Dalton D.S., et al. Treatment choice and quality of life in patients with choroidal melanoma. Arch. Ophthalmol. 117:1999;461-467
35. Parrish R.K., Gedde S.J., Scott I.U., Feuer W.J., Schiffman J.C., Mangione C.M., et al. Visual function and quality of life among patients with glaucoma. Arch. Ophthalmol. 115:1997;1447-1455
36. Scott I.U., Smiddy W.E., Schiffman J., Feuer W.J., Pappas C.J. Quality of life of low-vision patients and the impact of low-vision services. Am. J. Ophthalmol. 128:1999;54-62
37. Mangione C.M., Phillips R.S., Lawrence M.G., Seddon J.M., Orav E.J., Goldman L. Improved visual function and attenuation of declines in health-related quality of life after cataract extraction. Arch. Ophthalmol. 112:1994;1419-1425
38. Margolis M.K., Coyne K., Kennedy-Martin T., Baker T., Schein O., Revicki D.A. Vision-specific instruments for the assessment of health-related quality of life and visual functioning: a literature review. Pharmacoeconomics. 20:2002;791-812
39. Brown G.C. Vision and quality-of-life. Tr. Am. Ophth. Soc. XCVII:1999;473-511
40. Brown M.M., Brown G.C., Sharma S., Shah G. Utility values and diabetic retinopathy. Am. J. Ophthalmol. 128:1999;324-330
41. Derogatis LR, Lopez MC. The Psychological Adjustment to Illness Scale: Administration, Scoring and Procedures Manual 1. Towson: Clinical Psychometric Research; 1991.
42. Wulsin L.R., Jacobson A.M., Rand L.I. Psychosocial adjustment to advanced proliferative diabetic retinopathy. Diab. Care. 16:1993;1061-1066
43. Wulsin L.R., Jacobson A.M., Rand L.I. Psychosocial correlates of mild visual loss. Psychosom. Med. 53:1991;109-117
44. Mills R.P. Correlation of quality of life with clinical symptoms at the time of glaucoma diagnosis. Tr. Am. Ophth. Soc. XCVI:1998;753-812
45. Carroll TJ. Blindness: what it is, what it does and how to live with it. Boston: Little, Brown and Co.; 1961.
46. Bradley C., Todd C., Gorton T., Symonds L., Martin A., Plowright R. The development of an individualised questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL. Qual. Life Res. 8:1999;79-91
47. McGee H., O'Boyle C.A., Hickey A., O'Malley K., Joyce C.R.B. Assessing the quality of life of the individual: the SEIQoL with a healthy and a gastroenterology unit population. Psychol. Med. 21:1991;749-759
48. Kinmonth A.-L., Woodcock A., Griffin S., Spiegal N., Campbell M.J. Randomised controlled trial of patient centred care of diabetes in general practice: impact on current well-being and future disease risk. Br. Med. J. 317:1998;1202-1208
49. The DAFNE Study Group. Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial. Br Med J 2002;325:746-9.
50. Woodcock A.J., Julious S., Kinmonth A.L., Campbell M.J. Problems with performance of the SF-36 amongst people with Type 2 diabetes in General Practice. Qual. Life Res. 10:2001;661-670
51. Bradley C., Speight J. Patient perceptions of diabetes and diabetes therapy: assessing quality of life. Diab. Metab. Res. Rev. 18:2002;S64-S69
52. Greenhalgh J. Involving the user perspective in outcome measurement: an introduction. Outcomes Briefing Issue; 8 October 1996. p. 10-6.
53. Polonsky W.H. Understanding and assessing diabetes-specific quality of life. Diab. Spectrum. 13:2000;17-22
54. Bradley C. Design of a renal-dependent individualized quality of life questionnaire. Adv. Periton Dial. 13:1997;116-120
55. McMillan C., Bradley C., Gibney J., Healy M.L., Russell-Jones D.L., Sönksen P.H. Psychological effects of withdrawal of growth hormone therapy from adults with growth hormone deficiency. Clin. Endocrin. 59:2003;467-475
56. Mitchell J., Bradley C. Design of the MacDQoL individualized measure of the impact of macular disease on quality of life. Qual. Life Res. 11:2000;697
57. Bernbaum M., Albert S.G., Duckro P.N., Merkel W. Personal and family stress in individuals with diabetes and vision loss. J. Clin. Psychol. 49:1993;670-677
58. Mangione C.M., Lee P.P., Gutierrez P.R., Spritzer K., Berry S., Hays R.D. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch. Ophthalmol. 119:2001;1050-1058
59. Fichten C.S., Judd V., Tagalakis V., Amsel R., Robillard K. Communication cues used by people with and without visual impairments in daily conversations and dating. J. Vis. Impair Blind. 85:1991;371-378
60. Corn A.L., Sacks S.Z. The impact of nondriving on adults with visual impairments. J. Vis. Impair Blind. 88:1994;53-68
61. Bernbaum M., Albert S.S.G., Duckro P.N. Psychosocial profiles in patients with visual impairment due to diabetic retinopathy. Diab. Care. 11:1988;551-557
62. Trento M., Bajardi M., Borgo E., Passera P., Maurina M., Gibbins R., Owens D.R., Cavallo F., Porta M. Perceptions of diabetic retinopathy and screening procedures among diabetic people. Diab. Med. 19:2002;810-813
63. Scheiner G. Exercise options for people with diabetic eye complications. J. Ophthalmol. Nurs. Technol. 13:1994;267-269
64. Huppert F.A., Whittington J.E. Evidence for the independence of positive and negative well-being: Implications for quality of life assessment. Br. J. Health Psychol. 8:2003;107-122
65. Mitchell JD. Measurement of psychological well-being and quality of life in macular disease and investigation of factors influencing these outcomes. Unpublished PhD Thesis, Royal Holloway, University of London, 2003.
66. Mitchell J., Bradley C. Psychometric evaluation of the 12-item Well-being Questionnaire for use with people with macular disease. Qual. Life Res. 10:2001;465-473
67. Oehler-Giarratana J.W., Fitzgerald R.G. Group therapy with blind diabetics. Arch. Gen. Psychiatry. 37:1980;463-467
68. Bernbaum M., Albert S.G. Referring patients with diabetes and vision loss for rehabilitation: who is responsible? Diab. Care. 19:1996;175-177
69. Wolffe K.E., Roessler R.T., Schriner K.F. Employment concerns of people with blindness or visual impairments. J. Vis. Impair Blind. 86:1992;185-187
70. Jackson R., Lawson G. Family environment and psychological distress in persons who are visually impaired. J. Vis. Impair Blind. 89:1995;157-160
71. Beggs W.D.A. Coping, adjustment and mobility-related feelings of newly visually impaired young adults. J. Vis. Impair Blind. 86:1992;136-140
72. Bailey C.C., Sparrow J.M. Visual symptomatology in patients with sight-threatening diabetic retinopathy. Diab. Med. 8:2001;883-888
73. Oehler-Giarratana J.W. Meeting the psychosocial and rehabilitative needs of the visually impaired diabetic. J. Vis. Impair Blind. 71:1978;358-361
74. Oehler-Giarratana J. Diabetes and vision loss: improving the services of the American Diabetes Association. Diab. Care. 9:1986;95-96
75. Mangione C.M., Berry S., Spritzer K., Janz N.K., Klein R., Owsley C., Lee P. Identifying the content area for the 51-item National Eye Institute Visual Function Questionnaire: results from focus groups with visually impaired persons. Arch. Ophthalmol. 116:1998;227-233
76. Dodds A.G. Motivation reconsidered: the importance of self-efficacy in rehabilitation. Br. J. Vis. Impair. VII:1989;11-15
77. Dodds A.G., Bailey P., Pearson A., Yates L. Psychological factors in acquired visual impairment: the development of a scale of adjustment. J. Vis. Impair Blind. 85:1991;306-310
78. Cox D.J., Kiernan B.D., Schroeder D.B., Cowley M. Psychosocial sequelae of visual loss in diabetes. Diab. Educ. 24:1998;481-484